BrainG3N: A Dual-Purpose Tokenizer for Controllable 3D Brain MRI Generation

작성자

카테고리:

← 피드로
arXiv cs.AI · Max Van Puyvelde, Ibrahim Gulluk, Wim Van Criekinge, Olivier Gevaert · 2026-06-19 AI

[Submitted on 17 Jun 2026]

View PDF HTML (experimental)

Abstract:Three-dimensional (3D) brain MRI is central to clinical neurology and neuro-oncology, where generative models could augment under-represented cohorts, simulate disease trajectories, and support privacy-preserving data sharing. Latent diffusion has been the go-to solution for modeling imaging data, but it places two competing demands on the tokenizer: encoder embeddings must retain the clinical information that downstream tasks act on, and the decoder must reconstruct anatomically faithful volumes. Existing reconstruction-driven tokenizers achieve the second at the expense of the first. To address this, we introduce a fully volumetric masked-autoencoder (MAE) based tokenizer for 3D brain MRI latent diffusion, decoupling encoder and decoder: a frozen 3D MAE encoder produces clinically informative embeddings, while a dedicated CNN decoder reconstructs voxels from a linear projection of those embeddings. We pretrain the encoder on 35,309 volumes from 18 public cohorts spanning four modalities, ten disease categories, and 200+ acquisition sites, and demonstrate its dual utility in two settings. First, on a 23-task linear-probing benchmark, the encoder outperforms or matches SOTA models (i.e., BrainIAC, BrainSegFounder, and MedicalNet) on 21 of 23 tasks. Second, a conditional diffusion transformer (DiT) trained on these clinically informative embeddings supports both conditional generation across six variables and patient-specific longitudinal forecasting. Together these results establish a single 3D brain-MRI embedding space capable of both downstream clinical tasks and controllable generation.

Submission history

From: Max Van Puyvelde [view email]
[v1] Wed, 17 Jun 2026 23:14:16 UTC (5,277 KB)

원문에서 계속 ↗

추출 본문 · 출처: arxiv.org · https://arxiv.org/abs/2606.19651

코멘트

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 필드는 *로 표시됩니다